• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, BRASIL LTDA. SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, BRASIL LTDA. SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-23A
Device Problems Backflow (1064); Calcified (1077)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/06/2020
Event Type  Injury  
Manufacturer Narrative
Further information regarding this event has been requested.The results/ method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2013, a 23mm trifecta valve was implanted due to aortic stenosis.The valve was explanted on (b)(6) 2020, due to calcification.Upon explant pannus was noted on the subvalvular tissue of non-coronary cusp (ncc).An inspiris resilia aortic valve by edwards was implanted.The patient was reported to be stable condition.Additional information was requested but cannot be obtained.
 
Manufacturer Narrative
The reported calcification and pannus was confirmed.Leaflet 3 (rcc) contained calcifications, with a tear, associated with a calcification, noted near stent post 1.Circumferential pannus ingrowth was noted on both the inflow and outflow surfaces.This ingrowth encroached onto the inflow surface of all three leaflets, narrowing the inflow diameter.While the leaflet tissue was flexible, the mobility of all three leaflets was limited where calcifications or pannus was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.The host-device interaction of calcification and pannus limited valve function, with the calcification caused change in tissue architecture culminating in a leaflet tear.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, BRASIL LTDA.
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR  31310-260
MDR Report Key10013881
MDR Text Key189903356
Report Number3001883144-2020-00045
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05414734052030
UDI-Public05414734052030
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/30/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/26/2013
Device Model NumberTF-23A
Device Catalogue NumberTF-23A
Device Lot Number3704334
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/29/2020
Was the Report Sent to FDA? No
Date Manufacturer Received06/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age72 YR
-
-